Semustine

Jump to navigation Jump to search
Semustine
Semustine.png
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H18ClN3O2
Molar mass247.72 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Semustine

Articles

Most recent articles on Semustine

Most cited articles on Semustine

Review articles on Semustine

Articles on Semustine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Semustine

Images of Semustine

Photos of Semustine

Podcasts & MP3s on Semustine

Videos on Semustine

Evidence Based Medicine

Cochrane Collaboration on Semustine

Bandolier on Semustine

TRIP on Semustine

Clinical Trials

Ongoing Trials on Semustine at Clinical Trials.gov

Trial results on Semustine

Clinical Trials on Semustine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Semustine

NICE Guidance on Semustine

NHS PRODIGY Guidance

FDA on Semustine

CDC on Semustine

Books

Books on Semustine

News

Semustine in the news

Be alerted to news on Semustine

News trends on Semustine

Commentary

Blogs on Semustine

Definitions

Definitions of Semustine

Patient Resources / Community

Patient resources on Semustine

Discussion groups on Semustine

Patient Handouts on Semustine

Directions to Hospitals Treating Semustine

Risk calculators and risk factors for Semustine

Healthcare Provider Resources

Symptoms of Semustine

Causes & Risk Factors for Semustine

Diagnostic studies for Semustine

Treatment of Semustine

Continuing Medical Education (CME)

CME Programs on Semustine

International

Semustine en Espanol

Semustine en Francais

Business

Semustine in the Marketplace

Patents on Semustine

Experimental / Informatics

List of terms related to Semustine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.

References

  1. PMID 1548520 (PMID 1548520)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand